Boston

Boston, Massachusetts 02215

0 studies enrolling now · 7 studies all time

What they study most

Advanced Solid Tumors, C. Diff, C. Difficile, CDI, CRPC, Clostridium Difficile Infection, Clostridium Difficile Infection (CDI), Clostridium Difficile Infection Recurrence, FMT, Fecal Microbiota, Fecal Transplant, Genital Neoplasms, Male

Studies at this site

• A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study) — Running, not enrolling
• A Study of TRS01 in Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic Glaucoma — Completed
• Study to Evaluate OXERVATE® in Patients With Stage 1 Neurotrophic Keratitis — Completed
• Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3) — Completed
• A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts — Status unconfirmed
• Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff — Completed
• Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection — Completed